Evidence map›Paper›PMID 42417611›Full record

ArticleeLife2026

Autosomal allelic inactivation at loci with variable replication timing and dosage sensitivity.

Michael B Heskett, Athanasios E Vouzas, Brian Johnstone, Krister P Freese, Phillip A Yates, Philip F Copenhaver, Paul T Spellman, David M Gilbert, Mathew J Thayer

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Michael B HeskettDivision of Hematology Oncology, Departments of Medicine and Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.
Athanasios E VouzasSan Diego Biomedical Research Institute, San Diego, United States.
Brian JohnstoneDepartment of Orthopedics and Rehabilitation, Oregon Health and Science University, Portland, United States.
Krister P FreeseShriners Hospitals for Children - Portland, Portland, United States.
Phillip A YatesDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, United States.ORCID 0000-0003-2016-9789
Philip F CopenhaverDepartment of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, United States.ORCID 0000-0003-0918-3264
Paul T SpellmanDivision of Hematology Oncology, Departments of Medicine and Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.
David M GilbertSan Diego Biomedical Research Institute, San Diego, United States.ORCID 0000-0001-8087-9737
Mathew J ThayerDepartment of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, United States.ORCID 0000-0001-6483-1661

Funding

Genome Plasticity during ES Cell Differentiation to Neural LineagesR01GM083337 · NIGMS · SAN DIEGO BIOMEDICAL RESEARCH INSTITUTE · PI David M Gilbert · 2007 to 2026
$6.1M
The role of ASARs in chromosome dynamicsR01GM130703 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI THAYER, MATHEW J · 2019 to 2022
$1.2M
Allelic Expression Imbalance in Trisomy 21RF1NS142814 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI THAYER, MATHEW J · 2025 to 2025
$780k
NCI NIH HHS 4K00CA245677-03NIGMS NIH HHS R01GM083337NIGMS NIH HHS R01 GM130703NIGMS NIH HHS R01GM130703NINDS NIH HHS RF1 NS142814NINDS NIH HHS RF1NS142814
6 · The paper itself

Abstract

Autosomal monoallelic gene expression and asynchronous replication between alleles are established features of imprinted genes and genes regulated by allelic exclusion. Inactivation/Stability Centers (I/SCs) are recently described autosomal loci that exhibit epigenetic regulation of allelic expression and replication timing, with differences that can be comparable to those observed between the active and inactive X chromosomes . Here, we characterize >100 autosomal loci with allele-specific epigenetic regulation of replication timing and gene expression, defining them as I/SCs. I/SCs are approximately 1 Mbb in size and can contain both protein-coding and noncoding genes. In different single-cell derived clones, these genes may be expressed from a single allele, the opposite allele, both alleles, or not expressed at all. This stochastic, yet mitotically stable, pattern indicates that the choice of which allele is expressed is independent of parent of origin and independent of the expression status of the other allele. Similarly, alleles within I/SCs show varying replication timing, either earlier or later, that is also independent of the other allele. Additionally, we identify syntenic loci in the mouse genome that display epigenetic regulation of allelic replication timing, highlighting the genomic organization and conservation of I/SC-associated regulation between human and mouse genomes. The allele-restricted regulation described here creates extensive cellular mosaicism through a stable epigenetic mechanism. This mosaicism impacts numerous dosage-sensitive genes associated with human diseases such as Alzheimer, Parkinson, epilepsy, deafness, and impaired intellectual development.

Indexed as

AllelesDNA Replication TimingEpigenesis, GeneticGene DosageGene SilencingGenetic LociAnimalsHumansMiceDNA replicationepigeneticsgene expressiongeneticsgenomicshumanmouse

Identifiers

PMID42417611
PMCPMC13345637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.